share_log

Jefferies Upgrades ALX Oncology Holdings to Buy, Raises Price Target to $18

Jefferies Upgrades ALX Oncology Holdings to Buy, Raises Price Target to $18

杰富瑞集团上调ALX Oncology Holdings以买入,将目标股价提高至18美元
Benzinga ·  2023/12/08 06:27

Jefferies analyst Michael Yee upgrades ALX Oncology Holdings (NASDAQ:ALXO) from Hold to Buy and raises the price target from $8 to $18.

杰富瑞分析师迈克尔·伊将ALX Oncology Holdings(纳斯达克股票代码:ALXO)从持有上调至买入,并将目标股价从8美元上调至18美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发